IBXG logo

iBX Group, Inc. (IBXG) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören iBX Group, Inc. (IBXG), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 45/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 16 Mar 2026
45/100 AI Puanı

iBX Group, Inc. (IBXG) Sağlık ve Boru Hattı Genel Bakışı

CEOYoshiko Tomori Shale
Çalışanlar47
MerkezDeerfield Beach, US
Halka Arz Yılı2002
SektörHealthcare

iBX Group, Inc. provides administrative and technology solutions to the healthcare sector, operating through HTMT and PTR segments. Its offerings include practice management, billing services, and clinic operations. Facing a competitive landscape and negative gross margins, IBXG aims to serve healthcare providers with comprehensive support services.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

iBX Group, Inc. operates in the healthcare services sector, providing administrative and technological solutions. The company's two segments, HTMT and PTR, target different aspects of healthcare operations. However, with a negative gross margin of -164.0% and negative free cash flow, the company faces significant financial challenges. The high beta of 200.89 suggests extreme volatility relative to the market. Growth catalysts would likely depend on successful expansion of service offerings or improved operational efficiency. Investors should carefully consider the financial risks and competitive pressures before investing, given the OTC market listing and associated transparency concerns. The absence of a dividend further reduces its appeal for income-seeking investors.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Operates in two segments: Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR).
  • Provides administrative services, network support, and technology development to the healthcare industry.
  • Offers physician practice management, billing and collections, and staffing solutions through its HTMT segment.
  • Operates multidisciplinary clinics offering physical therapy, occupational medicine, and pain management through its PTR segment.
  • Based in Deerfield Beach, Florida, serving clients primarily in the United States.

Rakipler & Benzerleri

Güçlü Yönler

  • Comprehensive service offerings through HTMT and PTR segments.
  • Established relationships with healthcare providers.
  • Integrated approach to administrative and clinical services.
  • Experienced management team.

Zayıflıklar

  • Negative gross margin of -164.0%.
  • Negative free cash flow.
  • High beta indicating significant volatility.
  • Limited financial resources.

Katalizörler

  • Upcoming: Potential strategic partnerships with healthcare providers to expand service offerings.
  • Ongoing: Expansion of telehealth services to reach a broader patient base.
  • Ongoing: Enhancement of revenue cycle management services to improve financial performance.

Riskler

  • Potential: Intense competition in the healthcare services market.
  • Potential: Regulatory changes impacting healthcare operations.
  • Ongoing: Negative gross margin and free cash flow.
  • Ongoing: High beta indicating significant volatility.
  • Potential: Limited liquidity due to OTC market listing.

Büyüme Fırsatları

  • Expansion of Telehealth Services: The increasing adoption of telehealth presents a significant growth opportunity for iBX Group, Inc. By integrating telehealth solutions into its HTMT segment, the company can offer remote patient monitoring, virtual consultations, and online therapy services. The telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 23.5%. This expansion would allow iBX Group to reach a broader patient base and generate additional revenue streams, enhancing its competitive position in the healthcare sector. Timeline: Within the next 2-3 years.
  • Strategic Partnerships with Healthcare Providers: Forming strategic alliances with hospitals, clinics, and physician groups can drive growth for iBX Group, Inc. These partnerships can facilitate the integration of iBX's administrative and technology solutions into healthcare providers' existing workflows, improving efficiency and reducing operational costs. By leveraging these partnerships, iBX Group can secure long-term contracts and expand its market reach. This collaborative approach can lead to a more integrated and patient-centric healthcare delivery system. Timeline: Ongoing.
  • Enhancement of Revenue Cycle Management Services: Improving its revenue cycle management (RCM) services within the HTMT segment can significantly boost iBX Group, Inc.'s financial performance. By leveraging advanced analytics and automation, the company can optimize billing processes, reduce claim denials, and accelerate revenue collection. The global RCM market is expected to reach $107.4 billion by 2028, growing at a CAGR of 12.5%. Enhancing RCM capabilities would enable iBX Group to capture a larger share of this market and improve its financial stability. Timeline: Within the next 1-2 years.
  • Geographic Expansion of PTR Services: Expanding the geographic footprint of its Physical Therapy and Rehabilitation (PTR) services can drive growth for iBX Group, Inc. By opening new clinics in underserved areas or acquiring existing practices, the company can reach a wider patient population and increase its revenue base. The demand for physical therapy and rehabilitation services is growing due to the aging population and increasing prevalence of chronic conditions. This expansion would allow iBX Group to capitalize on this growing demand and strengthen its market position. Timeline: Over the next 3-5 years.
  • Development of Proprietary Healthcare Technology: Investing in the development of proprietary healthcare technology solutions can create a significant competitive advantage for iBX Group, Inc. By developing innovative software applications and platforms that address specific needs within the healthcare industry, the company can differentiate itself from competitors and attract new clients. This could include solutions for electronic health records (EHR), patient engagement, or data analytics. Proprietary technology can also generate recurring revenue streams through licensing and subscription models. Timeline: Ongoing.

Fırsatlar

  • Expansion of telehealth services.
  • Strategic partnerships with healthcare providers.
  • Enhancement of revenue cycle management services.
  • Geographic expansion of PTR services.

Tehditler

  • Intense competition in the healthcare services market.
  • Regulatory changes impacting healthcare operations.
  • Economic downturn affecting healthcare spending.
  • Technological advancements rendering existing services obsolete.

Rekabet Avantajları

  • Established presence in the healthcare administrative services market.
  • Integrated service offerings through HTMT and PTR segments.
  • Long-term relationships with healthcare providers.
  • Proprietary technology solutions for healthcare management.

IBXG Hakkında

Founded in 1997 as Vidkid Distribution, Inc., iBX Group, Inc. has evolved into a provider of administrative services, network support, and technology solutions primarily for the healthcare sector in the United States. The company operates through two main segments: Healthcare Transaction Management and Technology (HTMT) and Physical Therapy and Rehabilitation (PTR). The HTMT segment offers a suite of services including physician practice management, billing and collections, network services, transcription services, staffing solutions, and software application development. This segment aims to streamline administrative processes and enhance operational efficiency for healthcare providers. The PTR segment operates multidisciplinary clinics that provide physical therapy, occupational medicine, pain management, chiropractic care, and wellness services. These clinics offer integrated care to patients seeking rehabilitation and pain relief. Headquartered in Deerfield Beach, Florida, iBX Group, Inc. focuses on delivering comprehensive support services to healthcare clients.

Ne Yaparlar

  • Provides administrative services to healthcare clients.
  • Offers network support and maintenance.
  • Delivers technology development services.
  • Manages physician practices.
  • Handles billing and collections.
  • Provides transcription services.
  • Offers staffing solutions.
  • Develops software applications.

İş Modeli

  • Generates revenue through Healthcare Transaction Management and Technology (HTMT) services.
  • Generates revenue through Physical Therapy and Rehabilitation (PTR) services.
  • Offers administrative services on a contract basis.
  • Provides technology solutions through licensing and service agreements.

Sektör Bağlamı

iBX Group, Inc. operates within the healthcare services industry, which is characterized by increasing demand for administrative and technological solutions to manage complex healthcare operations. The industry is highly competitive, with companies like ACBM, AMBS, AXMP, DECN, and HDVY offering similar services. Market trends include the growing adoption of telehealth, increasing focus on value-based care, and the need for efficient revenue cycle management. iBX Group's success depends on its ability to differentiate its services and effectively compete in this dynamic environment.

Kilit Müşteriler

  • Physician practices
  • Hospitals and clinics
  • Healthcare networks
  • Rehabilitation centers
  • Individual patients seeking physical therapy
AI Güveni: 69% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

iBX Group, Inc. (IBXG) hisse senedi fiyatı: Price data unavailable

Son Haberler

IBXG için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

IBXG için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

IBXG için Wall Street fiyat hedefi analizi.

MoonshotScore

45/100

Bu puan ne anlama geliyor?

MoonshotScore, IBXG'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Yoshiko Tomori Shale

CEO

Yoshiko Tomori Shale is the CEO of iBX Group, Inc., managing a team of 47 employees. Her background includes extensive experience in healthcare administration and management. Prior to joining iBX Group, she held leadership positions in various healthcare organizations, focusing on operational efficiency and strategic growth. Her expertise spans across healthcare technology, revenue cycle management, and clinical operations. She is known for her ability to drive innovation and improve patient outcomes.

Sicil: Under Yoshiko Tomori Shale's leadership, iBX Group, Inc. has focused on expanding its service offerings and strengthening its relationships with healthcare providers. She has overseen the integration of new technologies into the company's HTMT segment and the expansion of its PTR services. Key milestones include the development of proprietary healthcare technology solutions and the implementation of strategic partnerships to drive growth. However, the company continues to face financial challenges, including negative gross margins and free cash flow.

IBXG OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that iBX Group, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and transparency compared to those listed on major exchanges like NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less regulatory oversight and information availability. This tier is generally associated with speculative investments.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for iBX Group, Inc. on the OTC market is likely limited, given its listing on the OTC Other tier. This typically translates to low trading volume and potentially wide bid-ask spreads, making it challenging to buy or sell shares quickly without significantly impacting the price. The limited liquidity can increase the risk of price volatility and make it difficult for investors to exit their positions, especially in large quantities.
OTC Risk Faktörleri:
  • Limited regulatory oversight and financial reporting requirements.
  • Low trading volume and liquidity.
  • Potential for price manipulation and volatility.
  • Higher risk of fraud or misrepresentation.
  • Limited access to company information and management.
Durum Tespiti Kontrol Listesi:
  • Verify the company's legal status and registration.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Check for any regulatory actions or legal disputes.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor or legal professional.
Meşruiyet Sinyalleri:
  • Company has been in operation since 1997.
  • Operates in the healthcare sector, providing essential services.
  • Has a CEO with experience in healthcare administration.
  • Maintains a physical headquarters in Deerfield Beach, Florida.

IBXG Healthcare Hisse Senedi SSS

IBXG için değerlendirilmesi gereken temel faktörler nelerdir?

iBX Group, Inc. (IBXG) şu anda yapay zeka skoru 45/100, düşük puanı gösteriyor. Temel güçlü yan: Comprehensive service offerings through HTMT and PTR segments.. İzlenmesi gereken birincil risk: Potential: Intense competition in the healthcare services market.. Bu bir finansal tavsiye değildir.

IBXG MoonshotScore'u nedir?

IBXG şu anda MoonshotScore'da 45/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

IBXG verileri ne sıklıkla güncellenir?

IBXG fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler IBXG hakkında ne diyor?

IBXG için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

IBXG'a yatırım yapmanın riskleri nelerdir?

IBXG için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition in the healthcare services market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

IBXG'ın P/E oranı nedir?

IBXG için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için IBXG'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

IBXG aşırı değerli mi, yoksa düşük değerli mi?

iBX Group, Inc. (IBXG)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

IBXG'ın temettü verimi nedir?

iBX Group, Inc. (IBXG) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is limited and may not be fully up-to-date.
  • OTC market investments carry higher risks than exchange-listed stocks.
  • AI analysis is pending and may provide further insights.
Veri Kaynakları

Popüler Hisseler